Donor Selection in T Cell—Replete Haploidentical Hematopoietic Stem Cell Transplantation: Knowns, Unknowns, and Controversies

Por Ciurea, Stefan O., Champlin, Richard E.
Publicado em 2012

Non-myeloablative Allogeneic Stem Cell Transplantation for Non-Hodgkin Lymphoma

Por Khouri, Issa F., Champlin, Richard E.
Publicado no Cancer J (2012)

NK cell therapy: targeting disease relapse after hematopoietic stem cell transplantation

Por Farhan, Shatha, Lee, Dean A., Champlin, Richard E., Ciurea, Stefan O.
Publicado em 2012

The synergistic cytotoxicity of clofarabine, fludarabine and busulfan in AML cells involves ATM pathway activation and chromatin remodeling

Por Valdez, Benigno C., Li, Yang, Murray, David, Champlin, Richard E., Andersson, Borje S.
Publicado em 2010

Phase II Study of Gonadotropin-Releasing Hormone Analog for Ovarian Function Preservation in Hematopoietic Stem Cell Transplantation Patients

Por Cheng, Yee Chung, Takagi, Mariko, Milbourne, Andrea, Champlin, Richard E., Ueno, Naoto T.
Publicado em 2012

FIFTY YEARS OF MELPHALAN USE IN HEMATOPOIETIC STEM CELL TRANSPLANTATION

Por Bayraktar, Ulas D., Bashir, Qaiser, Qazilbash, Muzaffar, Champlin, Richard E., Ciurea, Stefan O.
Publicado no Biol Blood Marrow Transplant (2012)

Increased Incidence of Fractures in Recipients of Hematopoietic Stem-Cell Transplantation

Por Pundole, Xerxes N., Barbo, Andrea G., Lin, Heather, Champlin, Richard E., Lu, Huifang
Publicado no J Clin Oncol (2015)

5-Aza-2′-deoxycytidine Sensitizes Busulfan-resistant Myeloid Leukemia Cells By Regulating Expression of Genes Involved in Cell Cycle Checkpoint and Apoptosis

Por Valdez, Benigno C., Li, Yang, Murray, David, Corn, Paul, Champlin, Richard E., Andersson, Borje S.
Publicado em 2009

Romiplostim for delayed platelet recovery and secondary thrombocytopenia following allogeneic stem cell transplantation

Por Poon, Limei Michelle, Stasi, Antonio Di, Popat, Uday, Champlin, Richard E, Ciurea, Stefan O
Publicado em 2013

Synergistic cytotoxicity of sorafenib with busulfan and nucleoside analogs in human FLT3-ITD-positive acute myeloid leukemia cells

Por Song, Guiyun, Valdez, Benigno C., Li, Yang, Liu, Yan, Champlin, Richard E., Andersson, Borje S.
Publicado no Biol Blood Marrow Transplant (2014)

Paclitaxel and Trastuzumab as Maintenance Therapy in Patients with HER2-Positive Metastatic Breast Cancer Who Underwent High-Dose Chemotherapy and Autologous Hematopoietic Stem Cel...

Por Cheng, Yee Chung, Rondón, Gabriela, Anderlini, Paolo, Khouri, Issa F., Champlin, Richard E., Ueno, Naoto T.
Publicado em 2013

Advances in myelofibrosis: a clinical case approach

Por Mascarenhas, John O., Orazi, Attilio, Bhalla, Kapil N., Champlin, Richard E., Harrison, Claire, Hoffman, Ronald
Publicado em 2013

Epigenetic modifiers enhance the synergistic cytotoxicity of combined nucleoside analog-DNA alkylating agents in lymphoma cell lines

Por Valdez, Benigno C., Nieto, Yago, Murray, David, Li, Yang, Wang, Guiyun, Champlin, Richard E., Andersson, Borje S.
Publicado em 2012

Synergistic cytotoxicity of the DNA alkylating agent busulfan, nucleoside analogs and SAHA in lymphoma cell lines

Por Valdez, Benigno C., Murray, David, Nieto, Yago, Li, Yang, Wang, Guiyun, Champlin, Richard E., Andersson, Borje S.
Publicado em 2011

Reduced-toxicity conditioning therapy with allogeneic stem cell transplantation for acute leukemia

Por Andersson, Borje S., de Lima, Marcos, Thall, Peter F., Madden, Timothy, Russell, James A., Champlin, Richard E.
Publicado em 2009

Infectious complications in cord blood and T-cell depleted haploidentical stem cell transplantation

Por Mulanovich, Victor E, Jiang, Ying, de Lima, Marcos, Shpall, Elizabeth J, Champlin, Richard E, Ciurea, Stefan O
Publicado em 2011

The histone deacetylase inhibitor SAHA sensitizes acute myeloid leukemia cells to a combination of nucleoside analogs and the DNA-alkylating agent busulfan

Por Song, Guiyun, Valdez, Benigno C., Li, Yang, Dominguez, Jose R., Corn, Paul, Champlin, Richard E., Andersson, Borje S.
Publicado no Leuk Lymphoma (2014)

Haploidentical Hematopoietic Stem Cell Transplantation as Platform for Post-transplant Cellular Therapy

Por Kongtim, Piyanuch, Lee, Dean A., Cooper, Laurence J. N., Kebriaei, Partow, Champlin, Richard E., Ciurea, Stefan O.
Publicado no Biol Blood Marrow Transplant (2015)

Hepatitis C virus infection in patients undergoing hematopoietic cell transplantation in the era of direct-acting antiviral agents

Por Kyvernitakis, Andreas, Mahale, Parag, Popat, Uday R., Jiang, Ying, Hosry, Jeff, Champlin, Richard E., Torres, Harrys A.
Publicado no Biol Blood Marrow Transplant (2015)

Chimeric Antigen Receptor (CAR)-Specific Monoclonal Antibody to Detect CD19-Specific T Cells in Clinical Trials

Por Jena, Bipulendu, Maiti, Sourindra, Huls, Helen, Singh, Harjeet, Lee, Dean A., Champlin, Richard E., Cooper, Laurence J. N.
Publicado em 2013